Registry for patients with recurrent pregnancy loss
Prospective Recurrent Pregnancy Loss (ProRPL) Registry
This study is collecting information from women who have had multiple pregnancy losses to see how different treatments and care options can help them over time.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 3000 (estimated) |
| Ages | 15 Years to 49 Years |
| Sex | Female |
| Sponsor | University of British Columbia Academic / other |
| Locations | 1 site (Vancouver, British Columbia) |
| Trial ID | NCT05989178 on ClinicalTrials.gov |
What this trial studies
This registry aims to collect and analyze data from patients experiencing recurrent pregnancy loss at the BC Women's Hospital. It will evaluate investigation practices, treatment options, and outcomes over time through a comprehensive approach that includes patient questionnaires and medical records. The program has been providing specialized care for 15 years and utilizes a collaborative model to support patients with clinical management and education. Data will be gathered from initial visits and follow-up questionnaires for up to five years.
Who should consider this trial
Good fit: Ideal candidates are women who have experienced two or more pregnancy losses before 20 weeks of gestation.
Not a fit: Patients seeking care for reasons other than recurrent pregnancy loss will not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could improve understanding and management of recurrent pregnancy loss, leading to better outcomes for affected patients.
How similar studies have performed: Other studies focusing on recurrent pregnancy loss have shown promise in improving patient outcomes, indicating that this approach may also be beneficial.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: • Patients seen at the BC Women's Recurrent Pregnancy Loss Clinic with recurrent pregnancy loss, defined as ≥2 pregnancy losses before 20 weeks of gestation. Exclusion Criteria: • Patients at BC Women's Recurrent Pregnancy Loss Clinic seen for reasons other than recurrent pregnancy loss.
Where this trial is running
Vancouver, British Columbia
- BC Women's Hospital & Health Centre — Vancouver, British Columbia, Canada (Recruiting)
Study contacts
- Principal investigator: Mohamed A. Bedaiwy, MD, PhD — BC Women's Hospital & Health Centre
- Study coordinator: Mohamed A. Bedaiwy, MD, PhD
- Email: mohamed.bedaiwy@cw.bc.ca
- Phone: 604-875-2000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.